Literature DB >> 17207579

Different mechanisms account for extracellular-signal regulated kinase activation in distinct brain regions following global ischemia and reperfusion.

Y Ho1, E Logue, C W Callaway, D B DeFranco.   

Abstract

Oxidative stress after cerebral ischemia and reperfusion activates extracellular signal-regulated kinases (ERK) in brain. However, the mechanism of this activation has not been elucidated. We have previously reported that in an in vitro model of oxidative stress in immature cortical neuronal cultures, the inhibition of ERK phosphatase activity contributes to ERK1/2 activation and subsequent neuronal toxicity. This study examined whether ERK activation was associated with altered activity of ERK phosphatases in a rat cardiac arrest model. Rats in experimental groups were subjected to asphyxial cardiac arrest for 8 min and then resuscitated for 30 min. Significant ERK activation was detected in both cortex and hippocampus following ischemia/reperfusion by immunoblotting. ERK phosphatase activity was reversibly inhibited in cerebral cortex but not affected in hippocampus following ischemia/reperfusion. MEK1/2 was activated in both cerebral cortex and hippocampus following ischemia/reperfusion. Using a specific inhibitor of protein phosphatase 2A (PP2A), okadaic acid (OA), we have identified PP2A to be the major ERK phosphatase that is responsible for regulating ERK activation in ischemic brain tissues. Orthovanadate inhibited ERK phosphatase activity in brain tissues, suggesting that tyrosine phosphatases and dual specificity phosphatases may also contribute to the ERK phosphatase activity in brain tissues. Together, these data implicate ERK phosphatase in the regulation of ERK activation in distinct brain regions following global ischemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207579      PMCID: PMC1859863          DOI: 10.1016/j.neuroscience.2006.11.039

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  39 in total

1.  Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.

Authors:  M Camps; A Nichols; C Gillieron; B Antonsson; M Muda; C Chabert; U Boschert; S Arkinstall
Journal:  Science       Date:  1998-05-22       Impact factor: 47.728

2.  Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice.

Authors:  S Kins; A Crameri; D R Evans; B A Hemmings; R M Nitsch; J Gotz
Journal:  J Biol Chem       Date:  2001-07-25       Impact factor: 5.157

3.  An automated system for regulating brain temperature in awake and freely moving rodents.

Authors:  F Colbourne; G R Sutherland; R N Auer
Journal:  J Neurosci Methods       Date:  1996-08       Impact factor: 2.390

4.  MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia.

Authors:  A Alessandrini; S Namura; M A Moskowitz; J V Bonventre
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

5.  Changes in the phosphorylation of initiation factor eIF-2alpha, elongation factor eEF-2 and p70 S6 kinase after transient focal cerebral ischaemia in mice.

Authors:  S Althausen; T Mengesdorf; G Mies; L Oláh; A C Nairn; C G Proud; W Paschen
Journal:  J Neurochem       Date:  2001-08       Impact factor: 5.372

6.  Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia.

Authors:  S Namura; K Iihara; S Takami; I Nagata; H Kikuchi; K Matsushita; M A Moskowitz; J V Bonventre; A Alessandrini
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  A reproducible model of circulatory arrest and remote resuscitation in rats for NMR investigation.

Authors:  S Liachenko; P Tang; R L Hamilton; Y Xu
Journal:  Stroke       Date:  1998-06       Impact factor: 7.914

8.  Impairment of phosphatase 2A contributes to the prolonged MAP kinase phosphorylation in Alzheimer's disease fibroblasts.

Authors:  Wei-Qin Zhao; Christina Feng; Daniel L Alkon
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

9.  Transient phosphatidylinositol 3-kinase inhibition protects immature primary cortical neurons from oxidative toxicity via suppression of extracellular signal-regulated kinase activation.

Authors:  David J Levinthal; Donald B DeFranco
Journal:  J Biol Chem       Date:  2004-01-08       Impact factor: 5.157

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  11 in total

1.  Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.

Authors:  Travis C Jackson; Jonathan D Verrier; Tomas Drabek; Keri Janesko-Feldman; Delbert G Gillespie; Thomas Uray; Cameron Dezfulian; Robert S Clark; Hülya Bayir; Edwin K Jackson; Patrick M Kochanek
Journal:  J Pharmacol Exp Ther       Date:  2013-09-10       Impact factor: 4.030

Review 2.  Intracellular zinc release, 12-lipoxygenase activation and MAPK dependent neuronal and oligodendroglial death.

Authors:  Yumin Zhang; Elias Aizenman; Donald B DeFranco; Paul A Rosenberg
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

3.  Mechanism of okadaic acid-induced neuronal death and the effect of estrogens.

Authors:  Kun Don Yi; Douglas F Covey; James W Simpkins
Journal:  J Neurochem       Date:  2008-11-28       Impact factor: 5.372

Review 4.  Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application.

Authors:  Pradip K Kamat; Shivika Rai; Supriya Swarnkar; Rakesh Shukla; Chandishwar Nath
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

5.  Protein phosphatases 1 and 2A are both required for long-term depression and associated dephosphorylation of cAMP response element binding protein in hippocampal area CA1 in vivo.

Authors:  Jocelyn C Mauna; Takeaki Miyamae; Benjamin Pulli; Edda Thiels
Journal:  Hippocampus       Date:  2010-09-07       Impact factor: 3.899

6.  Cisplatin-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) by inhibition of ERK1/2 phosphatases.

Authors:  Agata Gozdz; Aruna Vashishta; Katarzyna Kalita; Erzsebet Szatmari; Jing-Juan Zheng; Shigeo Tamiya; Nicholas A Delamere; Michal Hetman
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

7.  Selective inhibition of mitogen-activated protein kinase phosphatases by zinc accounts for extracellular signal-regulated kinase 1/2-dependent oxidative neuronal cell death.

Authors:  Yeung Ho; Ranmal Samarasinghe; Megan E Knoch; Marcia Lewis; Elias Aizenman; Donald B DeFranco
Journal:  Mol Pharmacol       Date:  2008-07-17       Impact factor: 4.436

8.  Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation.

Authors:  Manuela Basso; Jill Berlin; Li Xia; Sama F Sleiman; Brendan Ko; Renee Haskew-Layton; Eunhee Kim; Marc A Antonyak; Richard A Cerione; Siiri E Iismaa; Dianna Willis; Sunghee Cho; Rajiv R Ratan
Journal:  J Neurosci       Date:  2012-05-09       Impact factor: 6.167

9.  Neuroprotective signaling pathways are modulated by adenosine in the anoxia tolerant turtle.

Authors:  Gauri H Nayak; Howard M Prentice; Sarah L Milton
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-21       Impact factor: 6.200

10.  Ceramide from sphingomyelin hydrolysis differentially mediates mitogen-activated protein kinases (MAPKs) activation following cerebral ischemia in rat hippocampal CA1 subregion.

Authors:  Xian Sun; Chao Liu; Min Qian; Zhenghong Zhao; Jun Guo
Journal:  J Biomed Res       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.